Abbott Laboratories (Pakistan) Limited (PSX:ABOT)
950.75
+24.91 (2.69%)
At close: May 13, 2025
PSX:ABOT Revenue
Abbott Laboratories (Pakistan) had revenue of 17.35B PKR in the quarter ending March 31, 2025, with 8.22% growth. This brings the company's revenue in the last twelve months to 69.49B, up 20.45% year-over-year. In the year 2024, Abbott Laboratories (Pakistan) had annual revenue of 68.18B with 22.90% growth.
Revenue (ttm)
69.49B
Revenue Growth
+20.45%
P/S Ratio
1.34
Revenue / Employee
49.43M
Employees
1,406
Market Cap
93.08B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 68.18B | 12.70B | 22.90% |
Dec 31, 2023 | 55.48B | 6.22B | 12.62% |
Dec 31, 2022 | 49.26B | 6.69B | 15.71% |
Dec 31, 2021 | 42.57B | 7.29B | 20.65% |
Dec 31, 2020 | 35.28B | 5.13B | 17.00% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
GlaxoSmithKline Pakistan | 61.15B |
AGP Limited | 26.27B |
Highnoon Laboratories | 25.51B |
The Searle Company | 28.80B |
Shifa International Hospitals | 26.63B |
Citi Pharma | 13.19B |
Ferozsons Laboratories | 18.16B |
Otsuka Pakistan | 3.69B |